W. Fu et al. / Journal of Fluorine Chemistry 130 (2009) 996–1000
999
3. Conclusion
Calcd for C28H22Cl2FNO4S2: (%) C, 56.95; H, 3.76; N, 2.37. Found: C,
56.80; H, 3.98; N, 2.45.
In conclusion, we have disclosed the reactions of methylene-
cyclopropanes with N-F reagents to give the corresponding
fluorinated derivatives 2 and 4 in moderate to excellent yields.
Further studies, including the reaction mechanism and synthetic
application of this methodology, are in progress.
Compound 2e: white solid, mp 112–114 8C. 1H NMR (400 MHz,
CDCl3):
d 2.67 (t, J = 8.4 Hz, 2H), 3.94 (t, J = 8.4 Hz, 2H), 6.87 (d,
J = 8.0 Hz, 2H), 7.02 (d, J = 8.4 Hz, 2H), 7.17–7.26 (m, 3H), 7.32 (d,
J = 8.0 Hz, 2H), 7.45–7.51 (m, 4H), 7.60 (t, J = 8.0 Hz, 2H), 7.94 (d,
J = 8.0 Hz, 3H); 13C NMR (100 MHz, CDCl3):
d 31.7 (d, JC–F = 27.8 Hz),
46.3, 122.2(d, JC–F = 15.4 Hz), 126.1, 127.3, 128.6, 128.9, 129.0, 129.5,
130.5, 131.3, 132.0, 133.6, 135.4, 138.0, 138.2, 139.0, 148.6, 154.6(d,
JC–F = 261.2 Hz);MS(EI)m/z557(M+).Anal.CalcdforC28H22F3NO4S2:
(%) C, 60.31; H, 3.98; N, 2.51. Found: C, 60.45; H, 4.20; N, 2.42.
4. Experimental
4.1. General
Compound 2f: oil. 1H NMR (400 MHz, CDCl3):
d 2.31 (s, 0.6H),
Chemicals used were obtained from commercial suppliers and
used without further purifications. 1H NMR spectra and 13C NMR
spectra were measured in CDCl3 and recorded on Bruker Avance-
400 spectrometer (400 MHz for 1H NMR, 100 MHz for 13C NMR)
with TMS as an internal standard. IR spectra were run on a Bruker
vector 22 spectrometer. EIMS were determined with a HP5989B
mass spectrometer. Elemental analyses were performed on an EA-
1110 instrument.
2.34 (s, 2.4H), 2.61–2.72 (m, 2H), 3.91–3.98 (m, 2H), 5.43 (, d,
J = 38.0 Hz, 0.8H), 6.25 (d, J = 22.8 Hz, 0.2H), 6.80 (d, J = 8.0 Hz,
0.5H), 6.95 (s, 1H), 7.11–7.18 (m, 2H), 7.31 (d, J = 8.0 Hz, 2H), 7.49–
7.56 (m, 5H), 7.61–7.68 (m, 3H), 7.98–8.05 (m, 5.5H); 13C NMR
(100 MHz, CDCl3):
d 21.1, 21.3, 34.1 (d, JC–F = 27.2 Hz), 46.3, 108.2,
108.4, 127.2, 127.3, 128.1, 128.2, 128.31, 128.34, 128.4, 128.5,
128.9, 129.1, 129.2, 129.3, 129.6, 130.0, 130.10, 130.14, 131.9,
133.9, 134.0, 134.1, 134.8, 137.0, 139.0, 139.5, 139.7, 155.6 (d, JC–
F = 265.0 Hz); MS (EI) m/z 459 (M+). Anal. Calcd for C23H22FNO4S2:
(%) C, 60.11; H, 4.83; N, 3.05. Found: C, 60.23; H, 4.58; N, 3.20.
4.2. Typical procedure for fluorination of methylenecyclopropane 1
with N-fluorobenzenesulfonimide
Compound 2g: oil. 1H NMR (400 MHz, CDCl3):
d 2.73 (t,
J = 8.0 Hz, 2H), 3.76 (s, 3H), 3.81 (s, 3H), 3.96 (t, J = 8.0 Hz, 2H), 5.81
(d, J = 40.0 Hz, 1H), 7.53 (t, J = 8.4 Hz, 5H), 7.63–7.66 (m, 4H), 8.05
N-Fluorobenzenesulfonimide (0.5 mmol) was added to a stirred
solution of the methylenecyclopropane 1 (0.5 mmol) in THF
(5 mL). The mixture was stirred at 60 8C until the reaction
completed. The solvent was removed under reduced pressure
and the residue was purified by SiO2 gel column chromatography
to give the corresponding products 2.
(d, J = 8.0 Hz, 4H); 13C NMR (100 MHz, CDCl3):
d 34.3 (d, JC–
F = 27.5 Hz), 46.1, 55.4, 55.6, 98.1, 101.6, 104.8, 114.9, 127.6, 128.1,
129.0, 130.3, 130.4, 133.9, 139.6, 155.6 (d, JC–F = 256.5 Hz), 157.1,
159.8; MS (EI) m/z 505 (M+). Anal. Calcd for C24H24FNO6S2: (%) C,
57.02; H, 4.78; N, 2.77. Found: C, 57.26; H, 4.50; N, 2.91.
Compound 2a: white solid, mp 100–101 8C. 1H NMR (400 MHz,
Compound 2h: oil. 1H NMR (400 MHz, CDCl3):
2H), 3.96–3.99 (m, 2H), 6.93 (t, J = 8.8 Hz, 1H), 7.01–7.28 (m, 6H),
7.33–7.49 (m, 6H), 7.54–7.63 (m, 2H), 7.92 (, t, J = 9.6 Hz, 4H); 13
NMR (100 MHz, CDCl3): 31.5, 31.7 (d, JC–F = 26.8 Hz), 46.1, 46.2,
d 2.61–2.74 (m,
CDCl3):
(m, 7H), 7.36–7.41 (m, 7H), 7.60 (t, J = 7.6 Hz, 2H), 7.96 (d,
J = 7.6 Hz, 4H); 13C NMR (100 MHz, CDCl3):
31.7 (d, J = 27.2 Hz),
d 2.71 (t, J = 6.8 Hz, 2H), 3.97 (t, J = 6.8 Hz, 2H), 7.20–7.27
C
d
d
46.2, 122.8 (d, JC–F = 13.6 Hz), 127.2, 127.6, 128.0, 128.2, 128.5,
129.1, 129.4, 129.6, 130.0, 130.1, 134.0, 136.7, 138.0, 138.1, 139.5,
153.7 (d, JC–F = 260.2 Hz); MS (EI) m/z 521 (M+). Anal. Calcd for
114.8 (d, JC–F = 20.8 Hz), 115.6 (d, JC–F = 20.8 Hz), 121.80, 121.83,
121.93, 121.98, 127.0, 127.3, 127.8, 128.01, 128.06, 128.7, 129.1,
129.3, 129.4, 129.9, 130.0, 131.13, 131.18, 131.20, 131.26, 131.6,
131.72, 131.77, 132.7, 133.90, 133.93, 136.5, 137.7, 137.8, 139.50,
139.51, 153.6 (d, JC–F = 268.0 Hz), 153.7 (d, JC–F = 259.6 Hz), 161.7
(d, JC–F = 246.9 Hz), 162.2 (d, JC–F = 246.1 Hz); MS (EI) m/z 539 (M+).
Anal. Calcd for C28H23F2NO4S2: (%) C, 62.32; H, 4.30; N, 2.60. Found:
C, 62.25; H, 4.53; N, 2.71.
C28H24FNO4S2: (%) C, 64.47; H, 4.64; N, 2.69. Found: C, 64.41; H,
4.83; N, 2.58.
Compound 2b: oil, 1H NMR (400 MHz, CDCl3):
d 2.31 (s, 3H),
2.40 (s, 3H), 2.68 (t, J = 7.2 Hz, 2H), 3.99 (t, J = 7.2 Hz, 2H), 7.05–7.16
(m, 6H), 7.20 (d, J = 9.2 Hz, 2H), 7.44 (t, J = 8.0 Hz, 4H), 7.60 (d,
J = 8 Hz, 2H), 7.90 (d, J = 9.2 Hz, 4H); 13C NMR (100 MHz, CDCl3):
d
Compound 2i: oil. 1H NMR (400 MHz, CDCl3):
d 2.61–2.72 (m,
21.1, 21.2, 31.7 (d, JC–F = 27.2 Hz), 46.5, 122.4 (d, JC–F = 13.6 Hz),
128.0, 128.6, 129.1, 129.2, 129.4, 129.9, 133.7, 134.0, 135.1, 135.3,
136.8, 137.2, 139.5, 153.3 (d, JC–F = 259.1 Hz); MS (EI) m/z 549 (M+).
Anal. Calcd for C30H28FNO4S2: (%) C, 65.55; H, 5.13; N, 2.55. Found:
C, 65.48; H, 5.38; N, 2.62.
2H), 3.95–3.99 (m, 2H), 7.12 (d, J = 8.8 Hz, 1H), 7.15–7.36 (m, 6H),
7.35–7.45 (m, 2H), 7.44–7.53 (m, 4H), 7.54–7.64 (m, 2H), 7.88–7.91
(m, 4H); 13C NMR (100 MHz, CDCl3):
d 31.98 (d, JC–F = 25.8 Hz),
46.3, 121.7 (d, JC–F = 14.4 Hz), 127.3, 127.7, 127.8, 127.9, 128.6,
128.7, 128.9, 129.1, 129.3, 129.6, 130.4, 130.6, 131.2, 131.4, 132.8,
133.6, 133.7, 134.8, 136.1, 136.2, 136.3, 137.4, 139.3, 153.0 (d, JC–
F = 256.7 Hz), 153.8 (d, JC–F = 248.2 Hz); MS (EI) m/z 555 (M+). Anal.
Calcd for C28H23ClFNO4S2: (%) C, 60.48; H, 4.17; N, 2.52. Found: C,
60.45; H, 4.32; N, 2.61.
Compound 2c: oil. 1H NMR (400 MHz, CDCl3):
d2.69 (t,
J = 7.2 Hz, 2H), 3.78 (s, 3H), 3.84 (s, 3H), 4.02 (t, J = 7.2 Hz, 2H),
6.80 (d, J = 8.0 Hz, 2H), 6.96 (d, J = 8.8 Hz, 2H), 7.12 (d, J = 8.4 Hz,
2H), 7.22 (d, J = 8.4 Hz, 2H), 7.50 (t, J = 7.6 Hz, 4H), 7.61 (t, J = 7.6 Hz,
2H), 7.94 (d, J = 8.0 Hz, 4H); 13C NMR (100 MHz, CDCl3):
d
31.7 (d,
Compound 3a: white solid, mp 102–103 8C. 1H NMR (400 MHz,
JC–F = 27.9 Hz), 46.4, 55.0, 55.1, 113.2, 113.6, 114.0, 121.8(d, JC–
F = 13.4 Hz), 127.9, 128.4, 129.0, 129.3, 130.3, 130.4, 130.6, 130.7,
131.1, 133.7, 133.8, 139.5, 152.7 (d, JC–F = 257.8 Hz), 158.5, 158.9;
MS (EI) m/z 581 (M+). Anal. Calcd for C30H28FNO6S2: (%) C, 61.95; H,
4.85; N, 2.41. Found: C, 61.78; H, 5.10; N, 2.32.
CDCl3):
7.10 (m, 2H), 7.20–7.32 (m, 8H), 7.40–7.53 (m, 5H), 7.61–7.65 (m,
1H), 7.90–7.97 (m, 4H); 13C NMR (100 MHz, CDCl3):
30.3 (d, JC–
F = 27.8 Hz), 67.7, 126.7, 127.3, 127.7, 127.8, 128.6, 128.7, 129.2,
129.4, 130.0, 130.1, 132.5, 134.6, 135.5, 136.6, 142.6, 153.5 (d, JC–
F = 260.8 Hz); MS (EI) m/z 521 (M+). Anal. Calcd for C28H24FNO4S2:
(%) C, 64.47; H, 4.64; N, 2.69. Found: C, 64.36; H, 4.35; N, 2.78.
d 2.70 (dt, J = 20.0, 5.6 Hz, 2H), 4.41–4.50 (m, 2H), 7.07–
d
Compound 2d: white solid, mp 108–109 8C. 1H NMR (400 MHz,
CDCl3):
d 2.65 (t, J = 7.6 Hz, 2H), 3.95 (t, J = 7.6 Hz, 2H), 7.08 (d,
J = 8.0 Hz, 2H), 7.13 (d, J = 8.4 Hz, 2H), 7.22–7.30 (m, 3H), 7.35 (d,
J = 8.0 Hz, 2H), 7.44–7.52 (m, 4H), 7.64 (t, J = 8.0 Hz, 2H), 7.92 (d,
4.3. Typical procedure for fluorination of methylenecyclopropane 1
with F-TEDA-BF4
J = 8.0 Hz, 3H); 13C NMR (100 MHz, CDCl3):
d
31.8 (d, JC–
F = 27.0 Hz), 46.4, 122.6(d, JC–F = 14.2 Hz), 127.2, 127.5, 128.0,
128.1, 128.6, 129.0, 129.4, 129.5, 130.1, 130.2, 133.9, 136.8, 138.1,
138.2, 139.6, 153.7 (d, JC–F = 259.4 Hz); MS (EI) m/z 589 (M+). Anal.
1-Chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis
(tetrafluoroborate) (0.5 mmol) was added to a stirred solution of